JOHNSON & JOHNSON |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.56 CAD | +0.15% |
|
-1.95% | -7.52% |
| 28/06 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
| 28/06 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
4950c630280ebfe4e4949.NE6LK3YirMvGIb9wZV06c61_uKnhzF-6dUWkhcgqB80.WBjHEjFP24iyc_gCEgpSR9c4-vqNhhv_PQaX8qRtf49QLehPOEn_v4wW-g~7eb5d10354461c190c73cb73df789119
